CIDRZ’s Dr Ethel Kamuti honoured at the HIV Vaccine Trials Network full group meeting for outstanding work at the Matero Clinical Research Site.

Strengthening Zambia’s TB Response Through Evidence-Based Action, a Case of Early Tuberculosis Detection Through Repeat Contact Investigation.
May 7, 2026
U.S. Embassy Emphasises Critical Role of High-Quality Health Data During Copperbelt Data Verification Exercise.
May 11, 2026

CIDRZ’s Dr Ethel Kamuti honoured at the HIV Vaccine Trials Network full group meeting for outstanding work at the Matero Clinical Research Site.

We are pleased to share that Dr Ethel. M. Kamuti from the Centre for Infectious Disease Research in Zambia (CIDRZ) was honoured during the HIV Vaccine Trials Network (HVTN) full group meeting for her outstanding work at the Matero Clinical Research Site which has added value the HVTN enterprise.

She received the HVTN Service Award in recognition of her innovative and creative contributions to the network. The HVTN is a network of scientists, doctors, researchers and community members committed to ending HIV.

Congratulations, Dr Kamuti, on this well-deserved recognition and for your continued contribution to advancing HIV research globally.

Comments are closed.